A question of ethics: Selling autologous stem cell therapies flaunts professional standards
Authors:
Open Access
- 1 November 2014
- journal article
- review article
- Published by Elsevier in Stem Cell Research
- Vol. 13 (3) , 647-653
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Leaked files slam stem-cell therapyNature, 2014
- Fight for the right to stem cellsNew Scientist, 2013
- Don’t market stem-cell products ahead of proofNature, 2013
- Regulation of stem cell therapies under attack in Europe: for whom the bell tollsThe EMBO Journal, 2013
- Stem-cell ruling riles researchersNature, 2013
- The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicineNature Medicine, 2013
- Is belief larger than fact: expectations, optimism and reality for translational stem cell researchBMC Medicine, 2012
- The Promise and Perils of Stem Cell TherapeuticsCell Stem Cell, 2012
- The MSC: An Injury DrugstoreCell Stem Cell, 2011
- Medical Professionalism in the New Millennium: A Physician CharterAnnals of Internal Medicine, 2002